Skip to content

Can pharmacological stress test at MRI of the heart improve the detection of coronary stenoses/Kan belastningsprov i magnetkamera ge förbättrad diagnostik av kranskärlsförträngningar? - Infarct_MRI_dobutamine

Can pharmacological stress test at MRI of the heart improve the detection of coronary stenoses/Kan belastningsprov i magnetkamera ge förbättrad diagnostik av kranskärlsförträngningar? - Infarct_MRI_dobutamine

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001530-32-SE
Enrollment
60
Registered
2005-04-05
Start date
2006-09-28
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients in the first week post myocardial infarction are referred for early coronary angiography. Often, balloon dilatation is performed at the time of angiography. It is debatable which stenoses need dilatation and we would like to improve on the pre-cath information available by performing stress-MRI, using dobutamin as a physiological adjunct, in addition to infarct sizing with the late enhancement method (MRI).

Interventions

Sponsors

Jan Engvall
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients referred for coronary angiography within 7 days of hospital treatment for acute myocardial infarction, regardless of ST-elevation och non-ST-elevation infarction. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Usual contraindications for MRI, i.a. pacemaker/ICD, intracranial clips, claustrophobia, not willing to participate

Design outcomes

Primary

MeasureTime frame
Main Objective: Evaluate the best method to determine whether or not viability is present in an area of infarction.;Secondary Objective: ;Primary end point(s): Wall motion score recorded at echocardiography 3 months post intervention.

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026